US 9,931,294 Patent Landscape and Claim-Strength Analysis for Polyglyceryl Fatty Acid Ester + Sunscreen Skin-Care Emulsions
US Patent 9,931,294 claims skin-care compositions that combine (i) high oil loads, (ii) a narrow surfactant system defined by polyglyceryl fatty acid ester HLB 9 to 12 at 0.25% to 2.5%, and (iii) specific UV filters, with performance limits tied to stable non-phase-separated emulsions with no grainy texture for >8 weeks at 4°C to 45°C, and an absorption improvement relative to compositions using >2.5% surfactant. The estate is claim-dependent on both formulation chemistry and objective stability/texture tests, creating a mixed profile: broad coverage on oil + sunscreen selection, but heightened defensibility and potentially higher invalidity risk if the claimed “improved skin absorption” is not linked to structural features or supported with comparative data in the specification.
What is US 9,931,294 claiming and how broad is it?
Core claimed invention (independent claim 1):
A skin care composition comprising:
- 10%–90% by weight cosmetically acceptable oil
- Surfactant: 0.25%–2.5% total surfactant, and the surfactant “consists of” a polyglyceryl fatty acid ester with HLB 9–12, selected from:
- polyglyceryl-2 laurate (listed)
- polyglyceryl-10 dioleate (and) tocopherol (listed as written)
- polyglyceryl-6 dicaprate
- polyglyceryl-10 dioleate
- polyglyceryl-10 trilaurate
- combinations thereof
- Sunscreen active: defined by the claim set (dependent claims narrow)
- Product attributes: stable emulsion with aesthetically homogeneous phase, no visually perceptible phase separation, no grainy texture, and not inhomogeneous after >8 weeks at 4°C–45°C
- Functional performance: confers improved skin absorption versus formulations with surfactant >2.5%
Immediate claim breadth notes:
- The surfactant component is the narrowest patent “gate.” “Consists of” plus HLB 9–12 plus specific enumerated polyglyceryl fatty acid esters materially limits design-around space.
- Oil is broad in count (any cosmetically acceptable oil) but the surfactant system constrains the emulsion regime.
- Sunscreen filters are broad by dependent claim selection (classic organic UV filters and octocrylene/homosalate).
- The stability/texture shelf criteria are objective-looking, but the standard depends on what the patent defines as “grainy” and “visually perceptible signs.”
Key dependent claim expansions (and their constraint effect)
- Claim 2: oil at 50%–65%
- Claims 3–6: allows blends of synthetic esters and natural oils; natural oils named include rosa canina fruit oil, evening primrose oil, sweet almond oil, coconut oil; also named fatty acid ester oils include dicaprylyl carbonate, hexyl laurate
- Claims 7: surfactant narrow to 0.5%–2.0%
- Claims 8–9: sunscreen actives list and even a “includes each of” basket:
- butyloctyl salicylate
- butyl methoxydibenzoylmethane
- octocrylene
- ethylhexyl salicylate
- homosalate
- Claim 10: method of imparting sunscreen benefits by applying the composition
- Claim 11: a manufacturing method with heating, adding 0.25%–2.5% surfactant, mixing until homogeneous, cooling, then stability attributes
- Claim 12: a formulation claim that restates the surfactant system and stability criteria, plus a large optional additive basket
- Claims 13–18: further narrow oils/sunscreen load and add optional additives and a high sunscreen load condition (>10% sunscreen active in claims 16–17)
Which formulation elements are doing the legal work?
1) Surfactant definition (high impact on claim scope)
The surfactant must be:
- polyglyceryl fatty acid ester
- with HLB 9–12
- selected from a limited list
- present at 0.25%–2.5%
- and is stated to consist of those esters (language constraint)
Legal consequence: This is the main determinant of infringement for “composition” claims. If a competitor uses:
- a different surfactant class (e.g., non-polyglyceryl esters, PEG/cetyl systems, ether surfactants, nonionic ester blends outside HLB 9–12),
- or uses polyglyceryl esters outside HLB 9–12,
- or uses polyglyceryl esters outside the enumerated set,
then literal infringement weakens sharply.
2) Stability and texture limitations (good defense, litigation leverage)
The patent ties patentability to observable product properties:
- stable emulsion
- “aesthetically homogeneous phase”
- no visible phase separation
- no grainy texture
- no inhomogeneity for >8 weeks
- temperature stress 4°C to 45°C
Legal consequence: These limits can provide a factual infringement hook (does the competitor show phase separation/graininess under defined conditions?) while also potentially narrowing invalidity if the specification demonstrates that this stability/texture regime is not achieved by the prior art at the same surfactant load.
3) “Improved skin absorption” (functional performance clause)
The composition confers improved skin absorption vs compositions with >2.5% surfactant.
Legal consequence: This clause is a double-edged sword:
- It can strengthen novelty if the prior art teaches the same ingredients but at different surfactant levels without the absorption outcome.
- It can also create invalidity vulnerability if “improved absorption” is (i) inherent to the claimed emulsifier system, (ii) not adequately supported, or (iii) collapses into routine assay-dependent marketing claims.
What design-arounds exist against US 9,931,294 claim language?
Most direct design-around pathways:
- Surfactant type substitution
- Replace polyglyceryl fatty acid ester with another nonionic surfactant class or polyglyceryl derivative not in the list.
- HLB shift
- Keep total surfactant at 0.25%–2.5% but choose polyglyceryl esters outside HLB 9–12.
- Total surfactant outside range
- Use surfactant below 0.25% or above 2.5%.
- Note: the patent’s functional clause compares “improved absorption” vs >2.5%. That makes >2.5% a potential “escape” from both the numerical and functional scope, at least for independent claim 1.
- Texture/stability performance
- If a competitor’s emulsion shows grainy texture or visible phase separation after the specified time/temperature conditions, it is outside the claimed performance characterization (at least for infringement on “characterized as having maintained…”).
- Remove sunscreen actives from the defined set
- Dependent claims limit sunscreen actives; independent claim 1’s sunscreen active is still a “sunscreen active” but dependent claim narrowing suggests the most likely claimed infringement occurs where the same UV filters are used.
Higher-friction design-around:
- Competitors may need to preserve comparable sensory profile and absorption while shifting the surfactant chemistry. If the stability/texture requirements prove difficult, the engineering cost rises even when legal escape is available.
How would infringement be analyzed: composition vs method claims?
Composition claims (1, 2, 7, 8–9, 12–18):
- Infringement turns on whether a commercial product contains:
- an oil load in the claimed range (if asserted under claim 2/16)
- a surfactant system matching the polyglyceryl fatty acid ester list and HLB 9–12
- surfactant concentration within the claimed window
- specified sunscreen UV filters (if asserted under dependent claims 8–9, 14–15)
- and satisfies stability/texture performance under the specified conditions.
Method claims (10, 11):
- Claim 10 is a straightforward “apply composition” claim; it is typically easier to satisfy if the composition is made/used in commerce.
- Claim 11 adds a manufacturing method with heating and mixing steps. If a competitor uses a materially different manufacturing process, the method claim may be avoidable even if the end product is similar, depending on whether claim 11 is asserted separately.
What prior art patterns likely informed the claim?
Based on the claim structure, the patent appears to target a known formulation tension:
- many sunscreen emulsions use higher surfactant loads to stabilize UV filters and improve dispersion
- but higher surfactant levels can degrade skin feel, phase stability, or sensory attributes, and the patent asserts improved skin absorption using a low surfactant load defined by specific polyglyceryl HLB 9–12 esters
This implies the patent distinguishes from prior emulsifier systems by:
- narrowing surfactant chemotypes to polyglyceryl HLB 9–12 esters
- limiting total surfactant to <=2.5%
- anchoring inventive step to stability/texture after stress aging and to skin absorption improvement versus higher surfactant formulations
Where does the patent look strongest and where is it most vulnerable?
Strength vectors
- Ingredient precision: Polyglyceryl ester + HLB range + enumerated ester list is a strong claim delimiter.
- Product characteristics: Stability, homogeneity, lack of visible phase separation, and absence of graininess for >8 weeks at 4°C–45°C creates an objective performance boundary.
- “Consists of” language on the surfactant component: limits mixed surfactant systems if interpreted strictly.
Vulnerability vectors
- Functional performance clause (skin absorption):
- If “improved absorption” is not tightly correlated to the specific surfactant identities and concentrations, it risks being treated as conclusory or non-limiting in some analyses.
- If the patent’s examples compare to >2.5% surfactant without controlling other variables (oil phase, UV filter identity, droplet size distribution), the causal link may be challenged.
- Breadth on oil and optional additives:
- Allowing 10%–90% oil and a large optional additive set can invite arguments that the claim covers compositions that do not reproduce the claimed stability or absorption performance across the whole spectrum, depending on how much experimental support exists in the specification.
How many independent “claim buckets” exist and what does that mean for litigation strategy?
The claims cluster into three buckets:
- Surfactant + sunscreen + oil + stability + absorption (composition baseline)
- Surfactant + sunscreen + oil + stability with specific optional oil/additives and concentration sub-ranges (narrowing dependent layer)
- Process and use (method of forming and application)
Litigation positioning:
- If asserted against a competitor, the claimant typically targets the broadest bucket first: claim 1/12.
- If a competitor argues a surfactant-substitution or concentration difference, narrower dependent claims (oil 50%–65%, surfactant 0.5%–2.0%, sunscreen-specific basket, >10% sunscreen load) help preserve fallback coverage.
Competitive implications: what product profiles are most at risk?
Products with the most exposure are:
- emulsified sunscreen skin-care products using UV filters including at least one of the identified actives (butyloctyl salicylate; butyl methoxydibenzoylmethane; octocrylene; ethylhexyl salicylate; homosalate)
- with high oil phase loads and a low surfactant system that is polyglyceryl ester-based within HLB 9–12
- that maintain stable appearance with no phase separation/grainy texture after 8-week stability testing at refrigerated to elevated temperatures
Products with:
- higher surfactant loads (>2.5%)
- non-polyglyceryl emulsifiers
- polyglyceryl ester chemistries outside HLB 9–12
- or emulsions that show texture/phase instability in stress storage
are lower risk for literal infringement, though doctrine-based equivalents can still be argued depending on how strictly “consists of” and characterization language is construed.
Is the patent likely to deter Paragraph IV-style generic entry?
This is a cosmetics/OTC-style formulation patent rather than a drug substance patent. There is no Orange Book listing impact in the conventional NDA/ANDA sense because sunscreen skin-care compositions are not typically regulated via the same exclusivity framework.
The risk model is instead:
- reformulation lock-in via composition IP
- product performance testing during market entry
- potential licensing if the competitor needs the same sensory and stability outcomes and only the surfactant system differs
Paragraph IV is therefore not the direct framework; the patent landscape is managed via NDA-like exclusivity is not applicable, but through:
- settlement licensing,
- component substitution,
- and stability testing to avoid infringing performance characterizations.
Key Takeaways
- US 9,931,294 is centered on a narrow surfactant system: polyglyceryl fatty acid ester HLB 9–12 at 0.25%–2.5%, listed by specific ester members, in oil-rich sunscreen skin-care emulsions.
- The claim adds objective boundaries: no visible phase separation, no grainy texture, and stable appearance for >8 weeks at 4°C–45°C.
- “Improved skin absorption” is a major legal lever but also the main vulnerability if the record does not tightly link absorption outcomes to the specific surfactant system and concentration limits.
- Design-arounds most often succeed by changing surfactant chemistry, HLB target, surfactant concentration, or failing the stability/texture characterization under stress conditions.
- Litigation leverage comes from the combined chemical and performance limitations, but the breadth of allowable oils and additives raises support-related arguments depending on the specification’s breadth of examples.
FAQs
1) What surfactant systems fall within US 9,931,294’s literal scope?
Polyglyceryl fatty acid esters with HLB 9–12 from the enumerated list (e.g., polyglyceryl-2 laurate; polyglyceryl-6 dicaprate; polyglyceryl-10 dioleate; polyglyceryl-10 trilaurate; plus combinations as claimed) at 0.25%–2.5% total surfactant.
2) Does the patent protect a specific sunscreen filter combination or any sunscreen active?
The independent claim requires “a sunscreen active,” while dependent claims enumerate specific UV filters and can require inclusion of particular combinations.
3) How important is the “no grainy texture” language for infringement?
It is likely highly important where the claim is asserted based on product characterization. If a competitor’s formulation shows graininess or phase instability after the specified stress aging, infringement on those characterized limits weakens.
4) Can a competitor keep the same sunscreen actives but avoid infringement by changing the surfactant load?
Yes. Using surfactant outside 0.25%–2.5% can avoid both the numerical requirement and the absorption comparison embedded in the claim.
5) Are method-of-use and manufacturing method claims meaningful compared with composition claims?
Yes, but their value depends on the accused product’s manufacturing and use evidence. Composition claims typically present the strongest infringement path if the end product matches the chemical and performance limitations; manufacturing differences can narrow method-claim exposure.
References
No sources were provided or cited in the prompt.
